Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Benralizumab by AstraZeneca for Rhinosinusitis: Likelihood of Approval
Benralizumab is under clinical development by AstraZeneca and currently in Phase III for Rhinosinusitis. According to GlobalData, Phase III drugs...